GlassScriptPhysician profile
Samuel C Levine
NPI 1508954181
$150,931.92
in general payments reported to CMS, 2019-2025
2 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $20K · 2021: $20K · 2022: $20K · 2023: $24K · 2024: $25K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $73K · Consulting Fee: $2,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $72,535.86 |
| Consulting Fee | $2,510.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grace Medical, INC. | $142,995.96 | 2019-2025 | Levine Irrigation Suction Tubing |
| Preceptis Medical, INC. | $7,935.96 | 2020-2024 | Hummingbird Tympanostomy Tube System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.